Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy

NCT00008554 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Abacavir sulfate
DRUG: Nelfinavir mesylate
DRUG: Lamivudine
DRUG: GW433908

Sponsor

Glaxo Wellcome